Mauch Robert P.

COR President & CEO Mauch sold 3,762 shares at $358.94 (2/20/26); holds 65,393 shares post-sale

Robert P. Mauch, President & CEO of Cencora, executed a sale of 3,762 shares on 2026-02-20 at $358.94, reducing his holdings by 5.4% to 65,393 shares and realizing $1,350,332.28. The transaction occurred at a price 1.5% below the current market price of $364.38 and near the 52-week high of $374.75, suggesting the sale occurred near elevated valuation levels. His same-ticker sales history at COR shows mixed timing results: one prior sale (2025-09-18) was well-timed with an 18.3% post-sale decline over 90 days, but two other measurable sales declined post-transaction (2025-11-18 at -1.6% over 90 days and 2025-10-20 at +8.6% post-sale), indicating 1 of 3 prior same-ticker sells at COR were well-timed at the 90-day mark. His broader cross-ticker track record shows 16 prior open-market sales with an average 90-day return of +8.2%, suggesting his sells have generally been poorly timed historically, though his cross-ticker well-timed rate of 21.43% indicates modest predictive signal. The sale maintains substantial remaining exposure (65,393 shares), consistent with continued material equity stake in the company.

COR CEO Mauch sold 5,096 shares at $354.73 on 2026-01-20 for $1.8M; stock now at $352.47.

Robert P. Mauch, President & CEO of Cencora, sold 5,096 shares at $354.73, reducing holdings from 71,822 to 66,726 shares. The sale occurred near the 52-week high ($374.75), with the stock currently -6.0% from that peak, suggesting reasonable execution near recent strength. Mauch's same-ticker history at COR shows 5 prior sales over the past five months, with mixed 90-day timing results: 0 of 3 measurable sales were well-timed by the 90-day measure, and the two most recent sales (December and November 2025) have not yet produced measurable 90-day outcomes. His cross-ticker track record shows a 15.38% well-timed rate across 15 prior sells with an average 90-day return of +8.9%, indicating his sells historically have not preceded declines. The transaction value of $1.8M against a market cap of $68.4B represents a modest position adjustment for a company trading at a P/E of 35.21.

Cencora CEO Mauch sells 5,096 shares at $343.45; stock down 7.0% in 30 days, 90d prior sales showed mixed outcomes.

Mauch sold 5,096 shares (5.1K shares) at $343.45 on 2025-12-18, reducing his holdings from 73.2K to 68.1K shares (-7.0% net change). The stock has fallen 7.0% over the prior 30 days and is -9.3% from its 52-week high of $374.75. His cross-ticker track record shows 16.67% well-timed sells (low success rate), but at COR specifically, none of his 3 measurable prior 90-day sales were well-timed—the stock rose an average of +16.7% after those sales, meaning he sold before rallies. COR remains a large-cap growth name with 33.97 P/E and 9.3% annual revenue growth, trading at $340.03 currently (down 9.3% from peak), so the sale occurred into a sector or market headwind rather than a strategic exit from deteriorating fundamentals.

Cencora CEO Robert Mauch sold 5,096 shares at $366.64 for $1.9M, reducing holdings 7.2%; stock up 10.2% in 30 days post-sale.

Robert Mauch, President & CEO, sold 5,096 shares at $366.64 on 2025-11-18, reducing his holdings from 70,842 to 65,746 shares. The sale occurred near the 52-week high of $365.45. In his prior trades at Cencora, only 1 of 3 sales with measurable 90-day outcomes were well-timed (negative 90d return), while 2 resulted in subsequent gains (90d returns of +23.3% and +8.6%), indicating the stock often rose after his recent sales. His cross-ticker track record shows a 18.18% well-timed rate across 13 prior sells, suggesting mixed historical accuracy in capturing downside moves. The current price of $360.73 is only 1.3% below the 52-week high, leaving limited room for the stock to advance further, though the +10.2% 30-day gain since his sale represents price strength post-execution.

CEO Mauch sells 5,097 COR shares at $326.80 for $1.7M; stock now at $328.82 near 52-week high.

Robert P. Mauch, President & CEO, sold 5,097 shares of Cencora on 2025-10-20 at $326.80, reducing holdings from 43.0K to 37.9K shares (−11.8%). The sale occurred near the 52-week high of $328.82, with the stock up 13.4% over 30 days and 12.1% over 90 days. At this ticker, Mauch's prior five sales show mixed outcomes: one trade achieved +12.0% 30-day gain (2025-09-18), while others ranged from −1.5% to +1.8%, with only 1 of 3 measurable 90-day outcomes being well-timed (negative return after the sale). His cross-ticker track record spans 12 prior sells with a 20.00% well-timed rate at the 90-day mark and average 90-day return of +6.6%, indicating that on average his sells have been followed by stock appreciation rather than decline. The company reports solid fundamentals: $80.7B revenue, +12.1% annual growth, $687.4M net income, and a P/E of 33.59.

COR President & CEO Mauch sells 5,097 shares at $290.00 for $1.5M; holdings drop to 39.3K

Robert P. Mauch, President & CEO of Cencora, Inc., sold 5,097 shares at $290.00 on 2025-09-18, reducing his post-transaction holdings to 39,274 shares (a -11.5% reduction from pre-transaction holdings of 44,371 shares). The $1.5M transaction occurred near the stock's 52-week high of $304.58, with the stock currently trading at $288.79. Across his open-market history at multiple tickers, Mauch's 11 prior sells posted an average 90-day return of +6.3% with a well-timed rate of 22.22%, though at COR specifically, his prior 5 trades show mixed outcomes—only 1 of 3 measurable 90-day periods were well-timed (negative returns). The current sale follows a pattern of regular disposals at COR (monthly or near-monthly intervals dating back to April 2025), suggesting a systematic approach rather than a discrete event. Without additional context on plan adoption or vesting schedules, the timing and frequency warrant observation.

CEO Robert P. Mauch sold 4,968 shares of COR at $293.53; stock now trading -0.3% from 52-week high, post-sale holdings 40,608 shares.

CEO Robert P. Mauch sold 4,968 shares of Cencora on 2025-08-18 at $293.53 per share for a total value of $1,458,257.04, reducing his holdings from 45,576 shares to 40,608 shares. The stock is currently priced at $303.69, which is 0.3% below its 52-week high of $304.58. At the same-ticker level, Mauch's prior five trades at COR show mixed timing: of the three measurable 90-day outcomes, zero were well-timed sells (meaning the stock rose after each prior sale). His cross-ticker track record across 10 prior sales shows an average 90-day return of +7.3% with a well-timed rate of 12.50%, indicating his past sales have generally preceded gains rather than declines. The fundamental context remains strong: Cencora reported $80.7B in quarterly revenue with +12.1% annual growth and a market cap of $58.9B, though the stock trades at a P/E of 31.02. This sale occurs as the stock approaches its 52-week highs after a +3.8% gain in the past month, suggesting the trade happened near recent strength rather than weakness.

COR CEO Robert P. Mauch sold 4,968 shares at $294.11 (2025-07-18); stock now $292.97, -3.8% from 52-week high.

Robert P. Mauch, President & CEO of Cencora, sold 4,968 shares for $1,461,138.48, reducing his holdings by 10.5% from 47,319 to 42,351 shares. The sale occurred at $294.11, near the upper end of the 52-week range ($219.50–$304.58), though the stock has since declined modestly to $292.97. Examining his prior sales at Cencora specifically, Mauch's timing has been inconsistent: his three measurable prior sales showed 30-day returns ranging from -0.8% to +9.9%, with all three 90-day outcomes positive (range +1.2% to +12.1%), meaning he sold before stock rallies, not declines. His cross-ticker track record shows a 14.29% well-timed rate on nine prior sells—below the level that would suggest consistent prescience. With COR trading at a P/E of 33.52 and the company posting $75.5B in annual revenue with +12.1% growth, the CEO's discretionary sale into strength warrants observation for any broader strategic signals, though the modest 10.5% reduction and continued substantial ownership (42,351 shares) suggest no wholesale exit.

COR CEO Mauch sells 4,969 shares at $295.30; stock now $293.66 with P/E 33.60 and FY revenue growth +12.1%.

President & CEO Robert P. Mauch sold 4,969 shares (5.0K shares) of Cencora, Inc. (COR) at $295.30 on 2025-06-18, reducing his holdings by -10.1% to 44,094 shares. At the transaction price of $295.30, the stock was 3.6% below its 52-week high of $304.58, and has since declined to a current price of $293.66. Mauch's prior trades at COR show a timing pattern that does not consistently capture value: his 3 prior measurable 90-day outcomes all resulted in positive returns (+12.1%, +12.1%, +14.2%), meaning the stock rose after he sold—indicating his prior sales at this ticker were not well-timed in capturing downside protection. His cross-ticker track record yields a 90d well-timed rate of 16.67%, meaning his sell timing across all tickers has been poor historically. The company's fundamentals remain solid with FY revenue growth of +12.1%, a $75.5B quarterly revenue base, and a P/E of 33.60, which sits in a moderate valuation zone relative to growth. The sale itself represents a modest reduction in a substantial remaining position rather than a full exit.

Mauch (President & CEO) sold 4,969 shares of COR at $291.43; held 45.8K shares post-sale amid series of recent sales.

Mauch executed a sale of 4,969 shares on 2025-05-19 at $291.43, reducing holdings from 50.8K to 45.8K shares (-9.8% of prior holdings). This represents the sixth open-market sale by this insider in quick succession at Cencora within the past roughly 2.5 months (five prior trades documented in SAME-TICKER HISTORY, all concentrated between 2025-03-03 and 2025-04-21). The stock has appreciated 3.6% over the trailing 30 days and 19.7% over 90 days from the transaction date, and currently trades at $291.36, near the 52-week high of $304.58. Across his cross-ticker track record, his 7 prior sells averaged a 2.2% 90-day return after sale, suggesting historical portfolio exits have not consistently preceded declines. The rapid cadence of sales at a single ticker while the stock trades near all-time highs warrants attention to capital allocation rationale.